Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Plos One
|
July 25, 2019
Disutility associated with cancer screening programs: A systematic review
Lin Li, J L Hans Severens, Olena Mandrik
Journal of Psychosomatic Research
|
June 28, 2008
Determinants of health care use in chronic fatigue syndrome patients: a cross-sectional study
Korine Scheeres, Michel Wensing, Hans Severens, et al.
International Journal of Technology Assessment in Health Care
|
May 6, 2006
Are we measuring what matters in health technology assessment of disease management? Systematic literature review
Lotte Steuten, Bert Vrijhoef, Hans Severens, et al.
International Journal of Technology Assessment in Health Care
|
May 12, 2007
Cost-utility of a disease management program for patients with asthma
Lotte Steuten, Stephen Palmer, Bert Vrijhoef, et al.
Pharmacoeconomics
|
February 8, 2005
Measuring productivity changes in economic evaluation: setting the research agenda
Marc Koopmanschap, Alex Burdorf, Karin Jacob, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 28, 2015
The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses
Clazien Bouwmans, Marieke Krol, Hans Severens, et al.
International Journal of Cancer
|
February 15, 2019
Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening
Olena Mandrik, Nadine Zielonke, Filip Meheus, et al.
Global & Regional Health Technology Assessment
|
September 2, 2025
Paving the road for a successful EU HTA Reform implementation
Hans Severens, Andrew Dillon, Francois Meyer, et al.
Open Medicine (Warsaw, Poland)
|
March 30, 2017
Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine
Olena Mandrik, Saskia Knies, Olha Golubovska, et al.
Health Technology Assessment (Winchester, England)
|
March 25, 2014
Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
Penny Whiting, Maiwenn Al, Laura Burgers, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Plos One
|
July 25, 2019
Disutility associated with cancer screening programs: A systematic review
Lin Li, J L Hans Severens, Olena Mandrik
Journal of Psychosomatic Research
|
June 28, 2008
Determinants of health care use in chronic fatigue syndrome patients: a cross-sectional study
Korine Scheeres, Michel Wensing, Hans Severens, et al.
International Journal of Technology Assessment in Health Care
|
May 6, 2006
Are we measuring what matters in health technology assessment of disease management? Systematic literature review
Lotte Steuten, Bert Vrijhoef, Hans Severens, et al.
International Journal of Technology Assessment in Health Care
|
May 12, 2007
Cost-utility of a disease management program for patients with asthma
Lotte Steuten, Stephen Palmer, Bert Vrijhoef, et al.
Pharmacoeconomics
|
February 8, 2005
Measuring productivity changes in economic evaluation: setting the research agenda
Marc Koopmanschap, Alex Burdorf, Karin Jacob, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 28, 2015
The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses
Clazien Bouwmans, Marieke Krol, Hans Severens, et al.
International Journal of Cancer
|
February 15, 2019
Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening
Olena Mandrik, Nadine Zielonke, Filip Meheus, et al.
Global & Regional Health Technology Assessment
|
September 2, 2025
Paving the road for a successful EU HTA Reform implementation
Hans Severens, Andrew Dillon, Francois Meyer, et al.
Open Medicine (Warsaw, Poland)
|
March 30, 2017
Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine
Olena Mandrik, Saskia Knies, Olha Golubovska, et al.
Health Technology Assessment (Winchester, England)
|
March 25, 2014
Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
Penny Whiting, Maiwenn Al, Laura Burgers, et al.
Page
of 2